Sign in

CIK 0000034956 · Non-accelerated filer<br>Smaller reporting company

TENAX THERAPEUTICS, INC.

Sign in to watch
Ticker
TENX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
262593535
Phone
919-855-2100
Business address
101 GLEN LENNOX DRIVE, SUITE 300, CHAPEL HILL, NC, 27517
Former names
OXYGEN BIOTHERAPEUTICS, INC., SYNTHETIC BLOOD INTERNATIONAL INC
Open-market buys, last 90 days
$6,396,312
in 7 filings
Open-market sales, last 90 days
$0
in 0 filings

Net +$6,396,312. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. ADAR1 Capital Management, LLC +$6.3M 10% owner 4 filings
  2. Doogan Declan +$102K Director 1 filing
  3. Giordano Christopher Thomas +$20K CEO 1 filing
  4. STAAB THOMAS R II +$11K Chief Financial Officer 1 filing

Reading 73 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2021-06-11 Doogan Declan Director Option exercise +3,070,000 3,637,871
2021-06-11 Doogan Declan Director Option exercise · Series B Preferred Stock −3,070 0
2021-06-10 Almenoff June Sherie Director Grant or award · Stock Option (right to buy) +6,250 6,250
2021-06-10 Mitchum James P. Director Grant or award · Stock Option (right to buy) +5,000 5,000
2021-06-10 PROEHL GERALD T Director Grant or award · Stock Option (right to buy) +5,000 5,000
2021-06-10 Davidson Michael H. Director Grant or award · Stock Option (right to buy) +6,250 6,250
2021-06-10 Doogan Declan Director Grant or award · Stock Option (right to buy) +6,250 6,250
2021-01-15 Rich Stuart Chief Medical Officer Grant or award +662,517 662,517
2021-01-15 Rich Stuart Chief Medical Officer Grant or award +3,581 3,581
2021-01-15 Rich Stuart Chief Medical Officer Grant or award · Stock Option (right to buy) +250,000 250,000
2021-01-05 DiTonno Anthony A CEO Grant or award · Stock option (right to buy) +90,000 90,000
2021-01-05 Jebsen Michael B CFO Grant or award · Stock option (right to buy) +70,000 70,000
2020-09-08 ARMISTICE CAPITAL, LLC Director Purchase +8,543 $1.46 $12K 2,019,995
2020-09-08 ARMISTICE CAPITAL, LLC Director Purchase +0 2,019,995
2020-09-04 ARMISTICE CAPITAL, LLC Director Purchase +23,457 $1.41 $33K 2,011,452
2020-09-04 ARMISTICE CAPITAL, LLC Director Purchase +0 2,011,452
2020-09-03 ARMISTICE CAPITAL, LLC Director Purchase +36,000 $1.39 $50K 1,987,995
2020-09-03 ARMISTICE CAPITAL, LLC Director Purchase +0 1,987,995
2020-09-02 ARMISTICE CAPITAL, LLC Director Purchase +20,000 $1.47 $29K 1,951,995
2020-09-02 ARMISTICE CAPITAL, LLC Director Purchase +0 1,951,995

Page 6 of 9 · 172 trades